"i enjoyed the read and strongly agreed with and endorse this line of reasoning:
"And, yes, it would be nice if BIPH gave some guidance. But they are tight-lipped. For numerous reasons, of course."
for very logical reasons imo."
I agree the reasons for the radio silence are indeed likely to be logical.
It could be that if they gave guidance about when the Mytoech CSS device would actually enter clinical trials (if at all), then everybody would wonder what the hold up was this time, and why they wanted to expand the float to 800 million shares (and were prepared to spend $50,000 through a telemarketing company to get the quorum) given that commercialization wasn't going to be until 2010 earliest.
Or it could be that they have no guidance to give other than that they're going to use those 550 million new shares to reward their "management" and their various known associates in BioMed and TI.
The one thing that isn't logical is that they would sit on good news, or even just a coherent strategy to look after long term shareholders' interests and not release it. The one thing that could save this company is a realistic transparent communication showing an action plan with timed and costed milestones.
The fact that they won't do that simple thing could only be construed as good news by the most avid consumers of Biophan-brand Kool-Aid.
To vote either way on the expanded share float is to ensure that it gets issued, BTW. They already have the majority, now they need the quorum. If you want to stop the proposed MegaDilution, don't vote your shares at all.
Ironically, the way Biophan's "management" have rigged this vote, a vote against the dilution only makes it more likely to happen by creating the necessary number of total votes cast.
Exercise your democratic right by not enabling these chaps to render your Biophan shareholding even less valuable.
